LEADER 00891nam--2200301---450 001 990003679810203316 005 20220601121113.0 035 $a000367981 035 $aUSA01000367981 035 $a(ALEPH)000367981USA01 035 $a000367981 100 $a20120720d1973----km-y0itay50------ba 101 0 $afre 102 $aBE 105 $a||||||||001yy 200 1 $a<>oeil-de-boeuf et d'autres voyances$fPaul Dewalhens$gillustations de Willy Lecomte 210 $aBruxelles$cÉditions H. Fagne$d1973 215 $a52 p.$cill.$d19 cm 700 1$aDEWALHENS,$bPaul$0592812 702 1$aLECOMTE,$bWilly 801 0$aIT$bsalbc$gISBD 912 $a990003679810203316 951 $aXV.4.A. 2374$b237507 L.M.$cXV.4.A.$d00320078 959 $aBK 969 $aFF 979 $aMARIAS$b90$c20120720$lUSA01$h1432 996 $aOeil-de-boeuf et d'autres voyances$91140529 997 $aUNISA LEADER 02407nam 2200409z- 450 001 9910220034603321 005 20210211 035 $a(CKB)3800000000216431 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54525 035 $a(oapen)doab54525 035 $a(EXLCZ)993800000000216431 100 $a20202102d2016 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNeurophysiology in Alzheimer's Disease and Dementia 210 $cFrontiers Media SA$d2016 215 $a1 online resource (106 p.) 225 1 $aFrontiers Research Topics 311 08$a2-88919-930-4 330 $aAlzheimer's disease (AD) and dementia are the most common neurodegenerative disorder. Since the number of individuals with AD and dementia is expected to increase considerably in the near future, reliable treatment and diagnosis are critical. EEG and neurophysiological technique could be used as a cost-effective screening tool for early detection and diagnosis in the Mild Cognitive Impairment (MCI) stage. The aim in neurophysiology research is to develop signal processing methods that improve the specificity for diagnosing dementia; we wish to discover signal features that not only significantly differ in AD patients, but also allow us to reliably separate AD patients and control subjects. This approach is valuable for clinical purposes (as diagnostic tool for dementia), and it also more fundamentally contributes to a better understanding of brain dynamics of MCI patients. Finally, the development of neurophysiological biomarker could be useful in monitoring pharmacological treatments. The main focus of this special issue will be on the most recent developments and ideas in the field of EEG and neurophysiology which will enable us to extract features that improve the specificity for diagnosing AD and dementia. 606 $aNeurosciences$2bicssc 610 $aAlpha Rhythm 610 $aAlzheimer's disease 610 $aEEG 610 $aMMN 610 $aNeurophysiology 610 $atheta burst stimulation 610 $aTheta Rhythm 615 7$aNeurosciences 700 $aDavide Vito Moretti$4auth$01280382 906 $aBOOK 912 $a9910220034603321 996 $aNeurophysiology in Alzheimer's Disease and Dementia$93016854 997 $aUNINA